0001140361-17-028995.txt : 20170728 0001140361-17-028995.hdr.sgml : 20170728 20170728111209 ACCESSION NUMBER: 0001140361-17-028995 CONFORMED SUBMISSION TYPE: D PUBLIC DOCUMENT COUNT: 1 ITEM INFORMATION: 06b FILED AS OF DATE: 20170728 DATE AS OF CHANGE: 20170728 EFFECTIVENESS DATE: 20170728 FILER: COMPANY DATA: COMPANY CONFORMED NAME: BioMedomics, Inc. CENTRAL INDEX KEY: 0001595601 IRS NUMBER: 000000000 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: D SEC ACT: 1933 Act SEC FILE NUMBER: 021-291694 FILM NUMBER: 17988461 BUSINESS ADDRESS: STREET 1: 6 DAVIS DRIVE CITY: DURHAM STATE: NC ZIP: 27709 BUSINESS PHONE: 919-558-1210 MAIL ADDRESS: STREET 1: 6 DAVIS DRIVE CITY: DURHAM STATE: NC ZIP: 27709 D 1 primary_doc.xml X0708 D LIVE 0001595601 BioMedomics, Inc. 6 DAVIS DRIVE RESEARCH TRIANGLE PARK NC NORTH CAROLINA 27709 919-883-5542 DELAWARE None None Corporation true FRANK WANG 6 DAVIS DRIVE RESEARCH TRIANGLE PARK NC NORTH CAROLINA 27709 Executive Officer Director Chief Executive Officer TOM ROBERG 6 DAVIS DRIVE RESEARCH TRIANGLE PARK NC NORTH CAROLINA 27709 Director CAM PATTERSON 6 DAVIS DRIVE RESEARCH TRIANGLE PARK NC NORTH CAROLINA 27709 Director LIN WU 6 DAVIS DRIVE RESEARCH TRIANGLE PARK NC NORTH CAROLINA 27709 Director Biotechnology Decline to Disclose 06b false 2017-07-21 false true true false 0 2730000 530000 2200000 Includes $2,230,000 of new Series B-2 Convertible Preferred Stock and $500,000 Convertible Promissory Note (convertible in shares of B-2 Convertible Preferred Stock). false 1 0 0 0 false BioMedomics, Inc. J. Robert Tyler, III J. Robert Tyler, III Assistant Secretary 2017-07-28